Concentrations of Certain Antiseizure Meds Drop During Pregnancy

FRIDAY, Feb. 25, 2022 (HealthDay News) -- Among pregnant women with epilepsy, dose-normalized concentrations of several antiseizure medications decrease during pregnancy, according to a study published online Feb. 14 in JAMA Neurology.
Page B. Pennell, M.D., from University of Pittsburgh, and colleagues analyzed data from 430 women (aged 16 to 43 years) with epilepsy (326 pregnant participants and 104 nonpregnant control participants) to examine pregnancy-associated concentration changes for several antiseizure medications.
The researchers found that compared with postpartum values, dose-normalized concentrations during pregnancy were decreased by up to 56.1 percent for lamotrigine (15.60 to 6.85 μg/L/mg), 36.8 percent for levetiracetam (11.33 to 7.16 μg/L/mg), 17.3 percent for carbamazepine (11.56 to 7.97 μg/L/mg), 32.6 percent for oxcarbazepine (11.55 to 7.79 μg/L/mg), 30.6 percent for unbound oxcarbazepine (6.15 to 4.27 μg/L/mg), 39.9 percent for lacosamide (26.14 to 15.71 μg/L/mg), and 29.8 percent for zonisamide (40.12 to 28.15 μg/L/mg). Pregnancy dose-normalized median concentrations decreased significantly by week of gestational age compared with dose-normalized concentrations from control participants: carbamazepine, −0.14 μg/L/mg; carbamazepine unbound, −0.04 μg/L/mg; lacosamide, −0.23 μg/L/mg; lamotrigine, −0.20 μg/L/mg; levetiracetam, −0.06 μg/L/mg; oxcarbazepine, −0.14 μg/L/mg; oxcarbazepine unbound, −0.11 μg/L/mg; and zonisamide, −0.53 μg/L/mg.
"Results of this study suggest the need for higher doses of several antiseizure medications during pregnancy and support therapeutic drug monitoring beginning early in pregnancy," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
La obesidad podría acelerar la discapacidad en la EM
MIÉRCOLES, 2 de noviembre de 2022 (HealthDay News) -- La obesidad nunca es...
Health Highlights: March 2, 2023
Could the Mediterranean diet help people with MS? A study of more than 560...
Nearly Half of High-Risk Patients Delay Follow-Up After Lung Cancer Screening
WEDNESDAY, May 18, 2022 (HealthDay News) -- Annual lung cancer screenings are...
Los síntomas recientes de viruela del simio difieren de los de brotes anteriores
LUNES, 4 de julio de 2022 (HealthDay News) -- Los síntomas de los pacientes con...
